A

Arrivent Biopharma Inc
NASDAQ:AVBP

Watchlist Manager
Arrivent Biopharma Inc
NASDAQ:AVBP
Watchlist
Price: 19.53 USD -6.11% Market Closed
Market Cap: 806.2m USD

Income Statement

Earnings Waterfall
Arrivent Biopharma Inc

Revenue
0 USD
Operating Expenses
-162.4m USD
Operating Income
-162.4m USD
Other Expenses
11m USD
Net Income
-151.4m USD

Income Statement
Arrivent Biopharma Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(62)
(75)
(95)
(86)
(94)
(94)
(140)
(148)
(162)
Selling, General & Administrative
(8)
(10)
(13)
(13)
(15)
(15)
(17)
(19)
(21)
Research & Development
(54)
(65)
(82)
(73)
(79)
(79)
(123)
(129)
(141)
Operating Income
(62)
N/A
(75)
-20%
(95)
-28%
(86)
+10%
(94)
-9%
(94)
-1%
(140)
-49%
(148)
-6%
(162)
-9%
Pre-Tax Income
Interest Income Expense
3
5
9
11
13
14
13
11
11
Pre-Tax Income
(59)
N/A
(69)
-18%
(87)
-25%
(75)
+14%
(81)
-8%
(80)
+1%
(127)
-58%
(137)
-7%
(151)
-11%
Net Income
Income from Continuing Operations
(59)
(69)
(87)
(75)
(81)
(80)
(127)
(137)
(151)
Net Income (Common)
(59)
N/A
(69)
-18%
(87)
-25%
(75)
+14%
(81)
-8%
(80)
+1%
(127)
-58%
(137)
-7%
(151)
-11%
EPS (Diluted)
-1.84
N/A
-2.17
-18%
-3.46
-59%
-2.23
+36%
-2.41
-8%
-2.56
-6%
-3.78
-48%
-3.91
-3%
-3.61
+8%